logo

SGEN(Delisted)

SeagenยทNASDAQ
--
--(--)

SGEN Profile

Seagen Inc.

A biotechnology company that develops and commercializes targeted therapies to treat cancer

--
07/15/1997
03/06/2001
NASDAQ Stock Exchange
3,256
12-31
Common stock
21823 30th Drive SE , Bothell, WA 98021
--
Seagen Inc., was incorporated in Delaware on July 15, 1997. The company is a global biotechnology company dedicated to discovering, developing and commercializing transformable cancer drugs that can make a significant impact on people's lives. The company is headquartered in Seattle, Washington, and has branches in California, Canada, Switzerland and the European Union.